Hunter syndrome (MPS II) presentations will include analysis from continued follow-up of Phase 1/2 data for tividenofusp alfa (DNL310), currently under FDA Priority ReviewPreliminary data from Phase 1 ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy), to be presented (ACTRIMS) annual forum, being held February 5 – ...

This cross-disciplinary meeting highlights the latest discoveries, technologies and translational strategies driving the next generation of antimicrobial solutionsJERSEY CITY, N.J., Jan. 28, 2026 ...

Nizubaglustat is a small molecule, orally available and brain penetrant azasugar with a unique dual mode of action, developed as a potential treatment for rare lysosomal storage disorders with ...

Upon abstract acceptance, all posters must be uploaded and recorded on VoiceThread by January 26, 2026 at 5 p.m. All posters that are narrated on VoiceThread by the deadline will be officially listed ...

Real-world analyses suggest link to reduced steroid use, fewer hospital stays, lower morta ...

Researchers, Extension professionals, students and industry partners are invited to participate in the 2026 North Dakota ...

Wallace State Community College will host Innovations in Healthcare Simulation on April 24, a professional development workshop designed for educators and healthcare professionals who incorporate ...

Journées CORTICO 2026", the symposium in the fields of Brain-Computer Interfaces (BCI), Neurotechnology and Cognitive ...

Eight students from a solar physics research group led by Juie Shetye, New Mexico State University astronomy assistant ...

Scientific posters are often the first release of clinical data to the medical community. REVEAL is an end-to-end tailored platform that revolutionises the way scientific posters are created, enhanced ...